New formats needed 
Clinical trial data released this year in a study of cisgender men, transgender men, transgender women, and nonbinary individuals who have sex with partners assigned male at birth showed that using lenacapavir results in a 96% 
‘In my view, it’s analogous to dispensing a new drug that you haven’t come across before. You understand the relevant information related to the drug from a safety and effectiveness point of view, you communicate with the patient regarding relevant counselling points, and you document relevant information.’
Pregabalin add-on for drug-resistant focal epilepsy
This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1
Introduction
Approximately 3–3.5% of Australians will experience epilepsy at some point...
From the President: Pharmacists’ support valued during 2021
'I would like to take this opportunity to thank you for your valued support during 2021,' writes PSA National President A/Prof Chris Freeman.
Is Australia’s scope of care lagging behind?
Nations around the globe used to look to Australia for examples of bold and innovative pharmacy funding projects. But many of our overseas peers...
Budget’s funding welcome, but more is needed for pharmacy
PSA has welcomed the government’s commitment to pharmacy in the 2019-20 Federal Budget through the extension of the Administration Handling and Infrastructure (AHI) fee...
How should chronic pain in children be approached?
There is limited research on the effectiveness of pharmacotherapy in treating in children with chronic pain. So what is the best approach and how...
PSA NT/SA Branch’s vaccine advocacy work
The PSA SA/NT Branch is fighting for pharmacists to be able to administer more vaccines. Read more about it here.
